bosentan anhydrous has been researched along with Pulmonary Edema in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chilakapati, DR; Chilakapati, SR; Kanala, JR; Serasanambati, M; Vissavajjhala, P | 1 |
| Dorfmuller, P; Humbert, M; Jaïs, X; Montani, D; Simonneau, G; Sitbon, O | 1 |
| Carpenter, TC; Schomberg, S; Stenmark, KR | 1 |
| Gamberi, T; Gensini, GF; Mancia, G; Marchetta, M; Modesti, A; Modesti, PA; Morabito, M; Parati, G; Savia, G; Sofi, F; Vanni, S | 1 |
| Ercan, ZS; Hodoglugil, U; Sipahi, E; Türker, RK | 1 |
| Albertini, M; Ciminaghi, B; Clement, MG; Mazzola, S | 1 |
1 trial(s) available for bosentan anhydrous and Pulmonary Edema
| Article | Year |
|---|---|
Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study.
Topics: Acute Disease; Adaptation, Physiological; Adult; Altitude; Altitude Sickness; Arginine Vasopressin; Bosentan; Creatinine; Diuresis; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Female; Glomerular Filtration Rate; Humans; Hypertension, Pulmonary; Hypoxia; Kidney; Kidney Diseases; Male; Middle Aged; Muscle, Smooth, Vascular; Osmolar Concentration; Oxygen; Potassium Channels, Voltage-Gated; Pulmonary Artery; Pulmonary Edema; Receptors, Endothelin; Sulfonamides; Vasoconstriction | 2006 |
5 other study(ies) available for bosentan anhydrous and Pulmonary Edema
| Article | Year |
|---|---|
Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
Topics: Actins; Animals; Anti-Inflammatory Agents; Bleomycin; Bosentan; Catalase; Collagen Type I; Collagen Type II; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Lung; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Oxidative Stress; Peroxidase; Pneumonia; Pulmonary Edema; RNA, Messenger; Sulfonamides; Superoxide Dismutase; Time Factors | 2015 |
Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.
Topics: Bosentan; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Middle Aged; Piperazines; Pulmonary Edema; Pulmonary Medicine; Pulmonary Veno-Occlusive Disease; Purines; Risk; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia.
Topics: Animals; Antihypertensive Agents; Bosentan; Capillary Permeability; Endothelin Receptor Antagonists; Endothelins; Hypoxia; Male; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Respirovirus Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sendai virus; Serum Albumin; Sulfonamides; Vascular Endothelial Growth Factor A | 2005 |
Acute effect of endothelin-1 on lung oedema induced by alpha-naphthylthiourea (ANTU).
Topics: Angiotensin II; Animals; Aspartic Acid Endopeptidases; Body Weight; Bosentan; Endothelin-1; Endothelin-Converting Enzymes; Glycopeptides; Male; Metalloendopeptidases; Organ Size; Pleural Effusion; Protease Inhibitors; Pulmonary Edema; Rats; Sulfonamides; Thiourea | 1996 |
Improvement of respiratory function by bosentan during endotoxic shock in the pig.
Topics: Animals; Antihypertensive Agents; Bosentan; Enzyme Inhibitors; Female; Hypertension, Pulmonary; Lipopolysaccharides; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pulmonary Edema; Respiration; Shock, Septic; Sulfonamides; Swine; Time Factors | 2001 |